An integrated platform of imaging, AI-powered analysis and enrichment of viable cells.
Where AI Meets Living Cells
Product
Introducing the REM-I platform
The REM-I platform combines label-free imaging, deep learning, and gentle enrichment to leverage single cell morphology as a high-dimensional quantitative readout.
Focus Areas
Simple workflows. Endless possibilities.
Reveal tumor heterogeneity in unprecedented detail by profiling and sorting rare cancer cell populations without labels or destructive prep. REM-i enables deeper insights into resistance, progression, and therapeutic response.
Accelerate screening by linking cell morphology to functional outcomes in real time. REM-i uncovers early phenotypic signatures of efficacy, toxicity, and mechanism of action—de-risking pipelines and improving candidate selection.
Enhance quality control and manufacturing with high-resolution profiling of engineered cell products. REM-i identifies, enriches, and tracks therapeutically relevant cell states to ensure consistency, safety, and durability.
From regenerative medicine to transplant monitoring, neurobiology to agriculture, REM-i is expanding the boundaries of cell science, powering breakthroughs wherever living cells hold the key.
Want to keep in touch? Join our email list to stay up-to-date.
